Molecular mechanisms of glucocorticoid resistance in systemic lupus erythematosus: A review

Life Sci. 2018 Sep 15:209:383-387. doi: 10.1016/j.lfs.2018.08.038. Epub 2018 Aug 17.

Abstract

The treatment of systemic lupus erythematosus (SLE) with glucocorticoids (GCs) is quite effective; however, GC resistance or insensitivity is a major barrier to the treatment of SLE. Therefore, it is necessary to identify the underlying mechanisms that lead to GC resistance. Much evidence shows that the mechanism of GC resistance is very complicated. GC receptor is involved in the main mechanism of GC resistance and was illustrated by a lot of literature. Therefore, this paper focuses on the GC resistance mechanisms of non-glucocorticoids receptor, including P-gp, MIF, TLR9, and Th17 cells. These molecular mechanisms may help diagnose GC resistance and provide an alternative treatment strategy to reverse GC resistance by blocking the underlying mechanisms.

Keywords: Glucocorticoid resistance; Glucocorticoid sensitivity; Molecular mechanisms; Systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Drug Resistance*
  • Glucocorticoids / pharmacology*
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / pathology*

Substances

  • Glucocorticoids